Stock Options and Restricted Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended			12 Months Ended
		Jun. 15, 2018	Mar. 31, 2025		Mar. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Feb. 29, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option outstanding			889,928	[1]		913,909	959,522
Stock option exercisable			889,928	[1]		829,286
Unvested shares of common stock outstanding			0			84,623	261,875
Number of shares vested and settled			242,991
Unrecognized compensation cost related to unvested stock options, restricted stock, restricted stock units, and performance stock units			$ 9.0
Unrecognized compensation cost related to unvested stock options and restricted stock, recognition period			12 months
Total stock based compensation expense			$ 1.7		$ 1.5
Stock based compensation award per diluted common share			$ 0.07		$ 0.06
Intrinsic value of options vested			$ 0.1
Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding			338,757
Number of shares outstanding, vested restricted stock units			242,991
Restricted Stock Units [Member] | Vest on June 11, 2025 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, granted						92,350
Weighted average grant price, granted						$ 8.23
Restricted Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding			727,891	[2]		909,028	995,376
Number of shares vested and settled	[3]		484,823			400,985
Weighted average fair value of options granted			$ 0		$ 0
Number of shares, granted			307,059			347,158
Weighted average grant price, granted			$ 8.47			$ 9.17
PSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding			823,854			512,131	296,444
Number of shares vested and settled			0			0
Number of shares, granted			311,723			215,687
Weighted average grant price, granted			$ 8.47			$ 8.97
Unvested Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding, performance stock units			823,854
Maximum [Member] | PSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage							200.00%
Minimum [Member] | PSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage							0.00%
2018 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant			5,710,968
Shares were rolled into the 2018 Plan			399,439
2018 Equity Incentive Plan [Member] | Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding			95,766
2018 Restricted Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested shares of common stock outstanding			727,891
2015 Director Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant		258,334						300,000
2015 Director Plan [Member] | Non Employee Director One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant		12,000
2015 Director Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		10 years
Amended Director Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant								200,000
Number of additional shares available for issuance			0
Amended Director Plan [Member] | Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant			9,000
Amended Director Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		10 years

[1] The aggregate intrinsic value of outstanding options, which represents the difference between the price of the Company’s common stock at March 31, 2025 and the related exercise price of the underlying options, was $1.9 million for outstanding options, all of which had previously vested. The remaining contractual life was 4.9 years for outstanding options at March 31, 2025

[2] The aggregate fair value of the restricted stock was $6.3 million as of March 31, 2025. The remaining vesting period was 2.9 years at March 31, 2025.

[3] The aggregate fair value of the restricted stock vested was $4.2 million for the three months ended March 31, 2025 and $2.7 million for the year ended December 31, 2024